EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Oral intake of Lactiplantibacillus pentosus LPG1 Produces a Beneficial Regulation of Gut Microbiota in Healthy Persons: A Randomised, Placebo-Controlled, Single-Blind Trial

Elio López-García iD, Antonio Benítez-Cabello iD, Antonio Pablo Arenas-de Larriva, Francisco Miguel Gutierrez-Mariscal iD, Pablo Pérez-Martínez iD, Elena María Yubero-Serrano iD, Antonio Garrido-Fernández iD, Francisco Noé Arroyo-López iD

Nutrients · 2023

DOI: 10.3390/nu15081931 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Elio López-García und 7 weiteren Autor:innen. Beteiligte Einrichtung: Food Biotechnology Department. Instituto de la Grasa (CSIC), Carretera Utrera km 1, Campus Universitario Pablo de Olavide, Building 46, 41013 Seville…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish National Research Council, TOBE project, Spanish Ministry of Science and Innovation for his FPI contract.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for vegetable-origin probiotic microorganisms is a recent area of interest. This study conducted a phase I clinical trial to assess the effects of oral administration of Lactiplantibacillus pentosus LPG1, a natural strain with probiotic potential isolated from table olive fermentations, on the gut microbiota. The trial was a randomised, placebo-controlled, single-blind study involving 39 healthy volunteers. Group A (n = 20) ingested one capsule/day of L. pentosus LPG1 containing 1 × 1010 UFC/capsule, while Group B (n = 19) received one capsule/day containing only dextrose (placebo). The capsules were taken during breakfast for 30 consecutive days. Human stool samples were collected from all volunteers at the beginning (baseline) and at the end of the study (post-intervention) and were subjected to 16S rRNA metataxonomic analysis using Illumina MiSeq. Sequencing data at the genus level were statistically analysed using traditional methods and compositional data analysis (CoDA). After treatment, the alpha diversity in Group B (placebo) decreased according to an increase in the Berger and Parker dominance index (p-value < 0.05); moreover, dominance D increased and Simpson 1-D index decreased (p-value < 0.10). The Lactobacillus genus in the faeces was included in the CoDA signature balances (selbal and coda4microbiome) and played a notable role in distinguishing samples from baseline and post-intervention in Group A (LPG1). Additionally, ingesting L. pentosus LPG1 modified the gut microbiota post-intervention, increasing the presence of Parabacteroides and Agathobacter, but reducing Prevotella. These findings suggest that L. pentosus LPG1 is a potentially beneficial gut microbiota modulator in healthy persons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProbioticsHumansSingle-Blind MethodRNA, Ribosomal, 16SLactobacillusFermentation

Stichwörter der Autor:innen

compositional data analysis (CoDA)lactic acid bacteriametataxonomic analysisprobiotictable olivesvegetable fermenter

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Food Biotechnology Department. Instituto de la Grasa (CSIC), Carretera Utrera km 1, Campus Universitario Pablo de Olavide, Building 46, 41013 Seville, Spain.
  • Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, University of Córdoba, 14004 Córdoba, Spain.
  • CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Elio López-García, Antonio Benítez-Cabello, Francisco Miguel Gutierrez-Mariscal, Pablo Pérez-Martínez, Elena María Yubero-Serrano, Antonio Garrido-Fernández, Francisco Noé Arroyo-López

Förderung

  • Spanish National Research Council
  • TOBE project
  • Spanish Ministry of Science and Innovation for his FPI contract
  • the Junta de Andalucía for his contract
  • the Nicolas Monardes Programme from the “Servicio Andaluz de Salud, Junta de Andalucia”, Spain

Zitieren

APA

López-García, E., Benítez-Cabello, A., Arenas-de Larriva, A. P., Gutierrez-Mariscal, F. M., Pérez-Martínez, P., Yubero-Serrano, E. M., Garrido-Fernández, A., & Arroyo-López, F. N. (2023). Oral intake of Lactiplantibacillus pentosus LPG1 Produces a Beneficial Regulation of Gut Microbiota in Healthy Persons: A Randomised, Placebo-Controlled, Single-Blind Trial. Nutrients. https://doi.org/10.3390/nu15081931

Vancouver

López-García E, Benítez-Cabello A, Arenas-de Larriva AP, Gutierrez-Mariscal FM, Pérez-Martínez P, Yubero-Serrano EM, et al. Oral intake of Lactiplantibacillus pentosus LPG1 Produces a Beneficial Regulation of Gut Microbiota in Healthy Persons: A Randomised, Placebo-Controlled, Single-Blind Trial. Nutrients. 2023. doi:10.3390/nu15081931

BibTeX
@article{LpezGarca2023,
  author = {López-García, Elio and Benítez-Cabello, Antonio and Arenas-de Larriva, Antonio Pablo and Gutierrez-Mariscal, Francisco Miguel and Pérez-Martínez, Pablo and Yubero-Serrano, Elena María and Garrido-Fernández, Antonio and Arroyo-López, Francisco Noé},
  title = {Oral intake of Lactiplantibacillus pentosus LPG1 Produces a Beneficial Regulation of Gut Microbiota in Healthy Persons: A Randomised, Placebo-Controlled, Single-Blind Trial},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15081931}
}
Kostenlos starten →